These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 12503276)

  • 1. [Use of Panzytrat in the replacement therapy of exocrine pancreatic insufficiency (an analytical review)].
    Karamysheva EI; Lobanova EG
    Eksp Klin Gastroenterol; 2002; (4):47-50, 132. PubMed ID: 12503276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic enzyme pharmacotherapy.
    Ferrone M; Raimondo M; Scolapio JS
    Pharmacotherapy; 2007 Jun; 27(6):910-20. PubMed ID: 17542772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of panzytrat--modern physiological enzyme preparation in complex therapy of pancreatic exocrine secretory insufficiency in cholelithiasis].
    Petukhov VA; Mironov AV; Semenov ZhS; Ustinov FS
    Eksp Klin Gastroenterol; 2009; (1):72-80. PubMed ID: 19551960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multicenter comparative study of a new formulation of pancreatin in gastro-resistant microgranules for the treatment of exocrine pancreatic insufficiency in children with mucoviscidosis].
    Duhamel JF; Vidailhet M; Le Luyer B; Douchain F; Jehanne M; Clavel R; Guillot M
    Ann Pediatr (Paris); 1988 Jan; 35(1):69-74. PubMed ID: 3284429
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the effectiveness of the preparation Panzytrat 20,000 U in the substitute treatment of chronic pancreatitis].
    Rydzewska G; Turecka-Kulesza E; Ciok J; Pietrzak J; Gabryelewicz A; Butruk E; Dzieniszewski J
    Wiad Lek; 1994 Oct; 47(19-20):738-44. PubMed ID: 7483619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
    Whitcomb DC; Lehman GA; Vasileva G; Malecka-Panas E; Gubergrits N; Shen Y; Sander-Struckmeier S; Caras S
    Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis.
    Littlewood JM; Connett GJ; Sander-Struckmeier S; Henniges F;
    Expert Opin Drug Saf; 2011 Mar; 10(2):197-203. PubMed ID: 21342076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of pancreatic enzyme microsphere technology and US findings with Pancrease in the treatment of chronic pancreatitis.
    DeYoung JL
    Int J Pancreatol; 1989; 5 Suppl():31-6. PubMed ID: 2702248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Löhr JM; Hummel FM; Pirilis KT; Steinkamp G; Körner A; Henniges F
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1024-31. PubMed ID: 19352190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
    Kuhn RJ; Gelrud A; Munck A; Caras S
    Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension.
    Seiler CM; Izbicki J; Varga-Szabó L; Czakó L; Fiók J; Sperti C; Lerch MM; Pezzilli R; Vasileva G; Pap A; Varga M; Friess H
    Aliment Pharmacol Ther; 2013 Apr; 37(7):691-702. PubMed ID: 23383603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Piehl S; Brinkmann R; Windeck T
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):635-6; author reply 636-7. PubMed ID: 20393298
    [No Abstract]   [Full Text] [Related]  

  • 14. Pancreatic enzymes replacement therapy in chronic pancreatitis: an update.
    Trifan A; Balan G; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):646-50. PubMed ID: 12092213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
    Gottschalk B; Wiesemann HG; Stephan U
    Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
    Lankisch PG; Lembcke B; Göke B; Creutzfeldt W
    Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis to investigate the effect of concomitant use of gastric acid-suppressing drugs on the efficacy and safety of pancrelipase/pancreatin (CREON®) in patients with pancreatic exocrine insufficiency.
    Sander-Struckmeier S; Beckmann K; Janssen-van Solingen G; Pollack P
    Pancreas; 2013 Aug; 42(6):983-9. PubMed ID: 23587850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to: properties of different pancreatin preparations used in pancreatic exocrine insufficiency, Löhr JM et al. Eur J Gastroenterol Hepatol 2009; 21(9):1024-1031.
    Lederer PC
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):635; author reply 636-7. PubMed ID: 20393299
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of pancreatic insufficiency with a preparation containing high lipase activity].
    Pap A; Szilágyi V; Marosi E
    Orv Hetil; 1997 Mar; 138(10):601-4. PubMed ID: 9157336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.